Yongpeng Wang
Welcome,         Profile    Billing    Logout  
 0 Trials 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Yongpeng
NCT05585281: A Study of Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Recruiting
2
25
RoW
Fluzoparib, QL1101
Yongpeng Wang
Ovarian Cancer
11/25
12/25

Download Options